Tenaya Therapeutics, Inc.
TNYA
$0.4111
-$0.0028-0.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 8.35% | -6.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.71% | -7.71% | |||
| Operating Income | -11.71% | 7.71% | |||
| Income Before Tax | -12.70% | 7.01% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.70% | 7.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.70% | 7.01% | |||
| EBIT | -11.71% | 7.71% | |||
| EBITDA | -10.26% | 8.32% | |||
| EPS Basic | 11.38% | 7.26% | |||
| Normalized Basic EPS | 11.37% | 7.26% | |||
| EPS Diluted | 11.38% | 8.03% | |||
| Normalized Diluted EPS | 11.37% | 7.26% | |||
| Average Basic Shares Outstanding | 27.15% | 0.28% | |||
| Average Diluted Shares Outstanding | 27.15% | 0.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||